1. Home
  2. RMBI vs SGMT Comparison

RMBI vs SGMT Comparison

Compare RMBI & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richmond Mutual Bancorporation Inc.

RMBI

Richmond Mutual Bancorporation Inc.

HOLD

Current Price

$15.24

Market Cap

142.6M

Sector

Finance

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$7.76

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBI
SGMT
Founded
1887
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
142.6M
169.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
RMBI
SGMT
Price
$15.24
$7.76
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$26.13
AVG Volume (30 Days)
39.9K
2.6M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
3.85%
N/A
EPS Growth
27.17
N/A
EPS
1.17
N/A
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.77
$3.15
52 Week High
$16.04
$11.41

Technical Indicators

Market Signals
Indicator
RMBI
SGMT
Relative Strength Index (RSI) 64.03 63.02
Support Level $13.07 $6.61
Resistance Level N/A $7.86
Average True Range (ATR) 0.40 0.71
MACD 0.08 0.17
Stochastic Oscillator 64.92 60.08

Price Performance

Historical Comparison
RMBI
SGMT

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: